{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:31:40Z","timestamp":1793323900237,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973732"],"award-info":[{"award-number":["81973732"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074400"],"award-info":[{"award-number":["82074400"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20411"],"award-info":[{"award-number":["U21A20411"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.biopha.2022.112931","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T13:34:59Z","timestamp":1649338499000},"page":"112931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-\u03b2\/Smad"],"prefix":"10.1016","volume":"149","author":[{"given":"Junju","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuerong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.112931_bib1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.biopha.2022.112931_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112931_bib4","doi-asserted-by":"crossref","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","article-title":"TGF-\u03b2 signaling in the kidney: profibrotic and protective effects","volume":"310","author":"Sureshbabu","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.biopha.2022.112931_bib5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","article-title":"Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment","volume":"101","author":"Chen","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.biopha.2022.112931_bib6","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1681\/ASN.2007040484","article-title":"Latent TGF-beta1 protects against crescentic glomerulonephritis","volume":"19","author":"Huang","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18040877","article-title":"Regulation of ubiquitin enzymes in the TGF-\u03b2 pathway","volume":"18","author":"Iyengar","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1161\/HYPERTENSIONAHA.117.09600","article-title":"Deletion of angiotensin-converting Enzyme-2 promotes hypertensive nephropathy by targeting Smad7 for ubiquitin degradation","volume":"70","author":"Liu","year":"2017","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.biopha.2022.112931_bib10","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.febslet.2012.05.010","article-title":"Post-translational regulation of TGF-\u03b2 receptor and Smad signaling","volume":"586","author":"Xu","year":"2012","journal-title":"FEBS Lett."},{"issue":"15","key":"10.1016\/j.biopha.2022.112931_bib11","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1042\/CS20170127","article-title":"Smad7 protects against acute kidney injury by rescuing tubular epithelial cells from the G1 cell cycle arrest","volume":"131","author":"Fu","year":"2017","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.112931_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00441-011-1190-x","article-title":"Role of Smads in TGF\u03b2 signaling","volume":"347","author":"Heldin","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"10","key":"10.1016\/j.biopha.2022.112931_bib13","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/jcmm.13157","article-title":"Role of endothelial-to-mesenchymal transition induced by TGF-\u03b21 in transplant kidney interstitial fibrosis","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"issue":"16","key":"10.1016\/j.biopha.2022.112931_bib14","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1074\/jbc.C100008200","article-title":"Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation","volume":"276","author":"Ebisawa","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.biopha.2022.112931_bib15","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1073\/pnas.0400035101","article-title":"Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice","volume":"101","author":"Fukasawa","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.biopha.2022.112931_bib16","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/j.1349-7006.2008.00925.x","article-title":"Regulation of TGF-beta family signaling by E3 ubiquitin ligases","volume":"99","author":"Inoue","year":"2008","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.biopha.2022.112931_bib17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S1097-2765(00)00134-9","article-title":"Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation","volume":"6","author":"Kavsak","year":"2000","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib18","doi-asserted-by":"crossref","first-page":"F1076","DOI":"10.1152\/ajprenal.00323.2007","article-title":"Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication","volume":"294","author":"Tan","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib19","doi-asserted-by":"crossref","first-page":"F716","DOI":"10.1152\/ajprenal.00314.2016","article-title":"Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets","volume":"312","author":"Pichler","year":"2017","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/jbcpp-2017-0157","article-title":"Losartan improves renal function and pathology in obese ZSF-1 rats","volume":"29","author":"Su","year":"2018","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0960327114543840","article-title":"Losartan attenuates paraquat-induced pulmonary fibrosis in rats","volume":"34","author":"Guo","year":"2015","journal-title":"Hum. Exp. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2022.112931_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1155\/2012\/628268","article-title":"Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats","volume":"26","author":"Wengrower","year":"2012","journal-title":"Can. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.biopha.2022.112931_bib23","first-page":"1287","article-title":"Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan","volume":"115","author":"Yu","year":"2002","journal-title":"Chin. Med. J."},{"issue":"10","key":"10.1016\/j.biopha.2022.112931_bib24","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3109\/0886022X.2012.723775","article-title":"Losartan alleviates renal fibrosis by down-regulating HIF-1\u03b1 and up-regulating MMP-9\/TIMP-1 in rats with 5\/6 nephrectomy","volume":"34","author":"Fu","year":"2012","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3892\/mmr.2014.2304","article-title":"Losartan attenuates renal interstitial fibrosis and tubular cell apoptosis in a rat model of obstructive nephropathy","volume":"10","author":"He","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020305","article-title":"Anti-fibrotic effect of losartan, an angiotensin II receptor blocker, is mediated through inhibition of ER stress via Up-regulation of SIRT1, followed by induction of HO-1 and thioredoxin","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom9040141","article-title":"Unilateral ureteral obstruction as a model to investigate fibrosis-attenuating treatments","volume":"9","author":"Mart\u00ednez-Klimova","year":"2019","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.biopha.2022.112931_bib28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1007\/s11255-019-02253-8","article-title":"Losartan accelerates the repair process of renal fibrosis in UUO mouse after the surgical recanalization by upregulating the expression of Tregs","volume":"51","author":"Song","year":"2019","journal-title":"Int Urol. Nephrol."},{"issue":"11","key":"10.1016\/j.biopha.2022.112931_bib29","doi-asserted-by":"crossref","first-page":"F1555","DOI":"10.1152\/ajprenal.00157.2013","article-title":"Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice","volume":"305","author":"Liu","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2022.112931_bib30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/B:MCBI.0000026068.38301.cf","article-title":"Losartan reverses fibrotic changes in cortical renal tissue induced by ischemia or ischemia-reperfusion without changes in renal function","volume":"260","author":"Barrilli","year":"2004","journal-title":"Mol. Cell. Biochem."},{"issue":"4 Pt 2","key":"10.1016\/j.biopha.2022.112931_bib31","first-page":"F491","article-title":"Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril","volume":"269","author":"Burdmann","year":"1995","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2022.112931_bib32","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/ana.24147","article-title":"Losartan prevents acquired epilepsy via TGF-\u03b2 signaling suppression","volume":"75","author":"Bar-Klein","year":"2014","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155730","article-title":"Losartan attenuates myocardial endothelial-to-mesenchymal transition in spontaneous hypertensive rats via inhibiting TGF-\u03b2\/Smad signaling","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2022.112931_bib34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2009.86","article-title":"Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy","volume":"75","author":"Chevalier","year":"2009","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.112931_bib35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fphar.2018.01213","article-title":"Losartan alleviates renal fibrosis and inhibits endothelial-to-mesenchymal transition (EMT) under high-fat diet-induced hyperglycemia","volume":"9","author":"Yao","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.V132431","article-title":"Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats","volume":"13","author":"Debelle","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib37","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1159\/000443115","article-title":"HuangQi decoction ameliorates renal fibrosis via TGF-\u03b2\/Smad signaling pathway in vivo and in vitro","volume":"38","author":"Zhao","year":"2016","journal-title":"Cell Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib38","doi-asserted-by":"crossref","first-page":"F459","DOI":"10.1152\/ajprenal.00146.2014","article-title":"Chemokine receptor Cxcr4 contributes to kidney fibrosis via multiple effectors","volume":"308","author":"Yuan","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3892\/mmr.2021.12404","article-title":"High glucose\u2011induced upregulation of CD36 promotes inflammation stress via NF\u2011\u03baB in H9c2 cells","volume":"24","author":"Han","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2022.112931_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.aca.2013.01.015","article-title":"UPLC-ESI-QTOF\/MS and multivariate data analysis for blood plasma and serum metabolomics: effect of experimental artefacts and anticoagulant","volume":"768","author":"Barri","year":"2013","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib41","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/ac051312t","article-title":"Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry","volume":"78","author":"Want","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.biopha.2022.112931_bib42","doi-asserted-by":"crossref","first-page":"31424","DOI":"10.1038\/srep31424","article-title":"Exploratory metabolomics profiling in the kainic acid rat model reveals depletion of 25-Hydroxyvitamin D3 during epileptogenesis","volume":"6","author":"Heischmann","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2022.112931_bib43","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1242\/bio.017863","article-title":"Metabolomics reveals significant variations in metabolites and correlations regarding the maturation of walnuts (Juglans regia L.)","volume":"5","author":"Rao","year":"2016","journal-title":"Biol. Open"},{"key":"10.1016\/j.biopha.2022.112931_bib44","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1038\/ncomms5753","article-title":"Circadian rhythm reprogramming during lung inflammation","volume":"5","author":"Haspel","year":"2014","journal-title":"Nat. Commun."},{"issue":"7231","key":"10.1016\/j.biopha.2022.112931_bib45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nature07762","article-title":"Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression","volume":"457","author":"Sreekumar","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2022.112931_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","article-title":"Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets","volume":"820","author":"Lv","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"9811","key":"10.1016\/j.biopha.2022.112931_bib47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/ki.2013.387","article-title":"Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db\/db mice","volume":"85","author":"Reddy","year":"2014","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.biopha.2022.112931_bib49","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/acs.jafc.8b00099","article-title":"Novel RAS inhibitors poricoic acid ZG and poricoic acid ZH attenuate renal fibrosis via a Wnt\/\u03b2-catenin pathway and targeted phosphorylation of smad3 signaling","volume":"66","author":"Wang","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.biopha.2022.112931_bib50","doi-asserted-by":"crossref","first-page":"17741","DOI":"10.1038\/s41598-017-17437-4","article-title":"Safety and efficacy of Losartan 50\u2009mg in reducing blood pressure among patients with post-dialysis euvolemic hypertension: a randomized control trial","volume":"7","author":"Aftab","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ki.2015.320","article-title":"AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease","volume":"89","author":"Rodr\u00edguez-Romo","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.biopha.2022.112931_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cyto.2016.08.019","article-title":"The cellular and signalling alterations conducted by TGF-\u03b2 contributing to renal fibrosis","volume":"88","author":"Vega","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.biopha.2022.112931_bib53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.plipres.2014.01.002","article-title":"Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and sphingolipid species","volume":"54","author":"Ecker","year":"2014","journal-title":"Prog. Lipid Res."},{"issue":"5","key":"10.1016\/j.biopha.2022.112931_bib54","first-page":"636","article-title":"Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model","volume":"5","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.biopha.2022.112931_bib55","doi-asserted-by":"crossref","first-page":"22151","DOI":"10.1038\/srep22151","article-title":"An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2022.112931_bib56","article-title":"Rhubarb protect against tubulointerstitial fibrosis by inhibiting TGF-\u03b2\/Smad pathway and improving abnormal metabolome in chronic kidney disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib57","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/acs.jproteome.6b00956","article-title":"Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism","volume":"16","author":"Chen","year":"2017","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112931_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib59","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11255-014-0901-0","article-title":"Mechanism underlying an elevated serum bile acid level in chronic renal failure patients","volume":"47","author":"Chu","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.biopha.2022.112931_bib60","article-title":"Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis","volume":"7","author":"Li","year":"2019","journal-title":"PeerJ"},{"issue":"6","key":"10.1016\/j.biopha.2022.112931_bib61","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/acs.jproteome.6b00170","article-title":"Plasma lipidomics investigation of hemodialysis effects by using liquid chromatography-mass spectrometry","volume":"15","author":"Wang","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2022.112931_bib62","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.redox.2016.09.014","article-title":"Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression","volume":"10","author":"Chen","year":"2016","journal-title":"Redox Biol."},{"issue":"12","key":"10.1016\/j.biopha.2022.112931_bib63","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22282","article-title":"The construction of a panel of serum amino acids for the identification of early chronic kidney disease patients","volume":"32","author":"Li","year":"2018","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.biopha.2022.112931_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-030-45328-2_5","article-title":"Amino acid metabolism in the kidneys: nutritional and physiological significance","volume":"1265","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00726-013-1493-1","article-title":"Glycine metabolism in animals and humans: implications for nutrition and health","volume":"45","author":"Wang","year":"2013","journal-title":"Amino Acids"},{"issue":"3","key":"10.1016\/j.biopha.2022.112931_bib67","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/bph.14619","article-title":"Histamine in the kidneys: what is its role in renal pathophysiology?","volume":"177","author":"Grange","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.112931_bib68","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00726-009-0310-3","article-title":"Effects of glutamine supplementation on kidney of diabetic rat","volume":"38","author":"Alba-Loureiro","year":"2010","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib69","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.26698","article-title":"Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2022.112931_bib70","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/db10-0801","article-title":"Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet","volume":"60","author":"Tan","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.biopha.2022.112931_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2011.04.013","article-title":"Protection from obesity and diabetes by blockade of TGF-\u03b2\/Smad3 signaling","volume":"14","author":"Yadav","year":"2011","journal-title":"Cell Metab."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:31:32Z","timestamp":1774251092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":71,"alternative-id":["S0753332222003201"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112931","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-\u03b2\/Smad","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112931"}}